Flow Cytometry and Polymerase Chain Reaction-Based Analyses of Minimal Residual Disease in Chronic Lymphocytic Leukemia

New therapeutic strategies developed recently for chronic lymphocytic leukemia (CLL) have led to remarkable treatment response rates and complete hematological remissions. This means highly sensitive and specific techniques are increasingly needed to evaluate minimal residual disease (MRD) in CLL pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Uhrmacher, Sabrina, Erdfelder, Felix, Kreuzer, Karl-Anton
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2010
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2945647/
https://www.ncbi.nlm.nih.gov/pubmed/20886004
http://dx.doi.org/10.1155/2010/272517

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2945647/
https://www.ncbi.nlm.nih.gov/pubmed/20886004
http://dx.doi.org/10.1155/2010/272517

Ejemplares similares